Home › Esophageal Adenocarcinoma › Florida › Orlando
Esophageal Adenocarcinoma clinical trials in Orlando, FL
4 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- AdventHealth Orlando, Orlando
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Orlando
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Orlando
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Arlington, VA11 studies
- Nashville, TN11 studies
- Durham, NC10 studies
- Baldwin Park, CA9 studies
- Rochester, MN9 studies
- St. Louis, MO9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity32 studies
- Metastatic Cancer29 studies
- Overweight27 studies
- Alzheimer's Disease25 studies
- Type 2 Diabetes25 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Colorectal Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.